{
  "id": 1459,
  "text": "In terms of efficacy, pairwise meta-analyses showed that the 5-year OS rates of CCRT (cisplatin) and CCRT (cisplatin $+ ~ 5$ fluorouracil $^ +$ hydroxyurea) were higher than CCRT (hydroxyrea).There were no significant differences in (1) the 5-year OS rates among the other CCRT regimens tested and (2) the overall response rates and 5-year DFS rate among the evaluated CCRT regimens (Table 37).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: In terms of efficacy, pairwise meta-analyses showed that the 5-year OS rates of CCRT (cisplatin) and CCRT (cisplatin $+ ~ 5$ fluorouracil $^ +$ hydroxyurea) were higher than CCRT (hydroxyrea).There were no significant differences in (1) the 5-year OS rates among the other CCRT regimens tested and (2) the overall response rates and 5-year DFS rate among the evaluated CCRT regimens (Table 37).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据最近的一些临床试验结果，使用顺铂作为主要药物的同步放化疗方案在提高宫颈癌患者的5年总生存率方面表现出较高的效果，尤其是顺铂联合5-氟尿嘧啶和羟基脲的组合。这种方案的5年总生存率比单独使用羟基脲作为同步放化疗方案要更高。其他方案之间的5年总生存率和总体反应率则没有显著差异。",
  "query": "基于近期的一些临床试验结果，哪种化疗方案在提高宫颈癌患者5年总生存率方面最为有效？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 基于近期的一些临床试验结果，哪种化疗方案在提高宫颈癌患者5年总生存率方面最为有效？\n\n<reference text>: In terms of efficacy, pairwise meta-analyses showed that the 5-year OS rates of CCRT (cisplatin) and CCRT (cisplatin $+ ~ 5$ fluorouracil $^ +$ hydroxyurea) were higher than CCRT (hydroxyrea).There were no significant differences in (1) the 5-year OS rates among the other CCRT regimens tested and (2) the overall response rates and 5-year DFS rate among the evaluated CCRT regimens (Table 37).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据最近的一些临床试验结果，使用顺铂作为主要药物的同步放化疗方案在提高宫颈癌患者的5年总生存率方面表现出较高的效果，尤其是顺铂联合5-氟尿嘧啶和羟基脲的组合。这种方案的5年总生存率比单独使用羟基脲作为同步放化疗方案要更高。其他方案之间的5年总生存率和总体反应率则没有显著差异。"
}